Imaging of pancreatic cancer: An overview.
Open accessThe DOI matches its OpenAlex record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Pancreatic cancer (PaCa) is the fourth leading cause of cancer-related death in the United States. The median size of pancreatic adenocarcinoma at the time of diagnosis is about 31 mm and has not changed significantly in last three decades despite major advances in imaging technology that can help diagnose increasingly smaller tumors. This is largely because patients are asymptomatic till late in course of pancreatic cancer or have nonspecific symptoms. Increased awareness of pancreatic cancer amongst the clinicians and knowledge of the available imaging modalities and their optimal use in evaluation of patients suspected to have pancreatic cancer can potentially help in diagnosing more early stage tumors. Another major challenge in the management of patients with pancreatic cancer involves reliable determination of resectability. Only about 10% of pancreatic adenocarcinomas are resectable at the time of diagnosis and would potentially benefit from a R0 surgical resection. The final determination of resectability cannot be made until late during surgical resection. Failure to identify unresectable tumor pre-operatively can result in considerable morbidity and mortality due to an unnecessary surgery. In this review, we review the relative advantages and shortcomings of imaging modalities available for evaluation of patients with suspected pancreatic cancer and for preoperative determination of resectability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Adenocarcinoma
Palazzo, L., Roseau, G., Gayet, B., Vilgrain, V., Belghiti, J., Fékété, F., & Paolaggi, J.-A. (1993) · Endoscopy · doi:10.1055/s-2007-1010273 · Cited by 403
Isoattenuating Pancreatic Adenocarcinoma at Multi–Detector Row CT: Secondary Signs
Prokesch, R. W., Chow, L. C., Beaulieu, C. F., Bammer, R., & Jeffrey, R. B. (2002) · Radiology · doi:10.1148/radiol.2243011284 · Cited by 337
Sheridan, M. B., Ward, J., Guthrie, J. A., Spencer, J. A., Craven, C. M., Wilson, D., Guillou, P. J., & Robinson, P. J. (1999) · American Journal of Roentgenology · doi:10.2214/ajr.173.3.10470884 · Cited by 149
Diabetes mellitus and pancreaticcancer mortality in a prospectivecohort of United States adults
Calle, E. E., Murphy, T. K., Rodriguez, C., Thun, M. J., & Heath, C. W. (1998) · Cancer Causes & Control · doi:10.1023/a:1008819701485 · Cited by 143
Indicative findings of pancreatic cancer in prediagnostic CT
Ahn, S. S., Kim, M.-J., Choi, J.-Y., Hong, H.-S., Chung, Y. E., & Lim, J. S. (2009) · European Radiology · doi:10.1007/s00330-009-1422-6 · Cited by 105
Cited by
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Hidalgo, M., Cascinu, S., Kleeff, J., Labianca, R., Löhr, J.-M., Neoptolemos, J., Real, F. X., Van Laethem, J.-L., & Heinemann, V. (2015) · Pancreatology · doi:10.1016/j.pan.2014.10.001 · Cited by 509
Stotz, M., Gerger, A., Eisner, F., Szkandera, J., Loibner, H., L Ress, A., Kornprat, P., A Zoughbi, W., Seggewies, F. S., Lackner, C., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.332 · Cited by 490
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
Nguyen, D.-H. T., Lee, E., Alimperti, S., Norgard, R. J., Wong, A., Lee, J. J.-K., Eyckmans, J., Stanger, B. Z., & Chen, C. S. (2019) · Science Advances · doi:10.1126/sciadv.aav6789 · Cited by 172
“…of tumor cells into the vasculature ( 8 – 10 ), followup in vivo studies in mice have not advanced our understanding of this phenomenon owing to the complexity of animal models ( 11 ) and challenges in spatiotemporal imaging of tumorvessel interactions in internal organs, such as pancreas ( 12 ).”
Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer
Tummers, W. S., Willmann, J. K., Bonsing, B. A., Vahrmeijer, A. L., Gambhir, S. S., & Swijnenburg, R.-J. (2018) · Pancreas · doi:10.1097/mpa.0000000000001075 · Cited by 50
AI-assisted tumor board decision-making in pancreatic oncology
Mergen, M., Busch, F., Schwarberg, B., Koldeweihe, P., Jungwirth, D., Sydlik, J., Maurer, H. C., Makowski, M. R., Spitzl, D., & Gassert, F. T. (2026) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-026-03444-x · Cited by 3
Metadata
- Authors
- Tummala, P., Junaidi, O., & Agarwal, B.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2011-09-01
- Volume
- 2
- Issue
- 3
- Pages
- 168-74
- OpenAlex
- W2108208627
- Cited by
- 94
- References
- 5
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imaging of pancreatic cancer: An overview. https://app.cochat.ai/papers/10.3978/j.issn.2078-6891.2011.036
- The paper
- Tummala, P., Junaidi, O., & Agarwal, B. (2011). Imaging of pancreatic cancer: An overview. PubMed. https://doi.org/10.3978/j.issn.2078-6891.2011.036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.